Effects of Neo40(TM) With Caffeine on Cycling Time Trial Performance

The University of Texas System (UT)

Status: Unknown

Conditions: Healthy

Treatments: Dietary Supplement: Placebo; Dietary Supplement: Nitrate supplement with caffeine

Study type: Interventional

Funder types: Other

Identifiers

NCT01710761

2012-05-0033

Details and patient eligibility

About

Acute supplementation of Neo40(TM), a nitrate lozenge, will improve cycling performance

Enrollment: 16 estimated patients

Sex: All

Ages: 21 to 49 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Regular commuter cyclist or spin class participant
• Male (VO2max < 50) or Female (VO2max < 45)
• Healthy
• Blood pressure below 140/90
• Non-smoker

Exclusion criteria

• Does not cycle 2-3 times/week
• Regular consumption of performance-enhancing substances
• Type I or Type II diabetes
• Renal, hepatic or cardiac disease
• Current infectious disease

Trial design

Primary purpose: Basic Science

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Triple Blind

---

16 participants in 2 patient groups, including a placebo group

Nitrate supplement with caffeine

Active Comparator group

Treatment:

Dietary Supplement: Nitrate supplement with caffeine

Placebo

Placebo Comparator group

Treatment:

Dietary Supplement: Placebo